Atlas Trials

Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma

Clinical trial NCT01408043 · TERMINATED

Trial details

NCT number
NCT01408043
Sponsor
Case Comprehensive Cancer Center
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adult Acute Lymphoblastic Leukemia in RemissionAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHepatosplenic T-cell LymphomaNodal Marginal Zone B-cell LymphomaNoncutaneous Extranodal LymphomaPeripheral T-cell LymphomaRecurrent Adult Burkitt Lymphoma
Start date
2011-10-01
Primary completion
2016-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.